E
Evolent Health, Inc. (EVH)
NYQ – Real Time Price. Currency in USD
2.21
-0.17 (-7.14%)
At close: Mar 27, 2026, 4:00 PM EDT
2.22
+0.01 (0.45%)
After-hours: Mar 27, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
2.21
-0.17 (-7.14%)
At close: Mar 27, 2026, 4:00 PM EDT
2.22
+0.01 (0.45%)
After-hours: Mar 27, 2026, 7:57 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.31 | 2.19 | 7.0 | |
| Quick ratio | 1.31 | 1.96 | 7.0 | |
| Debt to Equity | 2.38 | 1.16 | 2.0 | |
| Debt to Assets | 0.52 | 2.94 | 4.0 | |
| Interest coverage | -0.51 | -28.30 | 1.0 | |
| Weighted average score | 4.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.35B | 1.96B | 2.55B | 1.88B | 1.88B |
| Gross Profit | 246M | 337M | 248M | 283M | 283M |
| Operating Income | 5M | 31M | 2M | -4M | -4M |
| Net Income | -19M | -113M | -62M | -535M | -535M |
| EBITDA | 95M | 154M | 126M | 118M | 118M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 10.41 | -180.92 | 4.0 |
| Next quarter | 36.88 | 69.53 | 10 |
| Current year | 32.85 | 52.59 | 10 |
| Next year | 15.43 | 203.17 | 9.5 |
| Weighted average score | 8.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -2.25 | -1956.79 | 60 | 499.11 | 5.5 |
| Y/Y | -27.49 | -1781.98 | 500 | 226.73 | 5.5 |
| 3y average | 16.27 | -409.17 | -46.43 | 133.43 | 5.3 |
| 5y average | 19.18 | -219.46 | 924.04 | 13.56 | 7.0 |
| Weighted average score | 5.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $989.7M significantly exceeds cash reserves ($178.0M), raising financial stability concerns
Total current assets $506.4M exceed Total current liabilities $385.3M, highlighting excellent liquidity
Debt-to-equity ratio (2.4) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-0.5x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $41.0M, supporting its financial health